Defunct Company
Total Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
132
NCT03569267
A Study to Evaluate Safety and PK Profiles of OLX10010 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: May 21, 2018
Completion: Jun 27, 2019
NCT04877756
Study to Evaluate Efficacy of OLX10010 in Reducing Recurrence of Hypertrophic Scarring After Scar Revision Surgery
Phase: Phase 2
Start: Aug 19, 2021
Completion: Jul 12, 2023
NCT05038371
Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration
Phase: N/A
Role: Collaborator
Start: Sep 1, 2021
Completion: Sep 22, 2022
NCT05643118
Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration
Start: Jan 4, 2023
Completion: Dec 31, 2024